Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Eur Urol Focus. 2023 Jul;9(4):564-566. doi: 10.1016/j.euf.2023.03.025. Epub 2023 Apr 12.
Active surveillance (AS) has been proposed as a possible management option for patients with recurrent low-grade non-muscle-invasive bladder cancer. Recent studies suggest that AS is a safe and effective management strategy. Nevertheless, a consensus statement is needed to standardize inclusion criteria and follow-up schedules.
主动监测 (AS) 已被提议作为复发性低级别非肌肉浸润性膀胱癌患者的一种可能的治疗选择。最近的研究表明,AS 是一种安全有效的治疗策略。然而,需要达成共识来规范纳入标准和随访计划。